However, the measurement of soluble interleukin-2 receptor (sIL-2R) in CSF, although nonspecific, has emerged as a potentially useful biomarker for neurosarcoidosis, particularly in the absence of elevated angiotensin-converting enzyme (ACE) or lysozyme levels [5-7]. This evidence concerns the gene ACE and neurosarcoidosis.